Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer

Brain, Behavior, and Immunity

Volumn 23, Issue 5, 2009, Pages 580-591

  Antoni, Michael H ^a,b,c   Lechner, Suzanne ^b,c   Diaz, Alain ^b   Vargas, Sara ^a   Holley, Heather ^a   Phillips, Kristin ^a   McGregor, Bonnie ^d   Carver, Charles S ^a,c   Blomberg, Bonnie ^b,c  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Anxiety; Breast cancer; Cortisol; Relaxation; Stress management intervention; Th1 cytokines

Indexed keywords

ANTINEOPLASTIC AGENT; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ANXIETY; ANXIETY DISORDER; BLOOD SAMPLING; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; COGNITIVE BEHAVIORAL STRESS MANAGEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GUIDED IMAGERY; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; IMMUNOASSAY; MAJOR CLINICAL STUDY; MASTECTOMY; NEUROENDOCRINE SYSTEM; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSYCHOEDUCATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY; TH1 CELL; TREATMENT DURATION;

ADAPTATION, PHYSIOLOGICAL; ADAPTATION, PSYCHOLOGICAL; ADULT; AFFECT; ANXIETY; BREAST NEOPLASMS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYTOKINES; FEMALE; HUMANS; HYDROCORTISONE; IMMUNITY, CELLULAR; LYMPHOCYTE SUBSETS; MIDDLE AGED; NEUROIMMUNOMODULATION; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; STRESS, PSYCHOLOGICAL; TH1 CELLS; THINKING;

EID: 68649101202     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2008.09.005     Document Type: Review

References (91)

1. Altman D., Schulz K., Moher D., Egger M., Davidoff F., Elbourne D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann. Intern. Med. 134 (2001) 663-694
2. Alferi S.M., Carver C.S., Antoni M.H., Weiss S., and Duran R.E. An exploratory study of social support, distress, and life disruption among low-income Hispanic women under treatment for early stage breast cancer. Health Psychol. 20 (2001) 41-46
3. American Cancer Society (2007). Cancer Statistics. Available from: http://www.cancer.org.
4. Andersen B.L., Farrar W.B., Golden-Kreutz D., Kutz L.A., MacCallum R., Courtney M.E., et al. Stress and immune responses after surgical treatment for regional breast cancer. J. Natl. Cancer Inst. 90 (1998) 30-36
5. Andersen B.L., Farrar W.B., Golden-Kreutz D.M., Glaser R., Emery C.F., Crespin T.R., et al. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J. Clin. Oncol. 22 (2004) 3570-3580
6. Andersen B.L., Kiecolt-Glaser J.K., and Glaser R. A biobehavioral model of cancer stress and disease course. American Journal of Psychology 49 (1994) 389-404
7. Andersen B.L., Farrar W.B., Golden-Kreutz D.M., Emery C.F., Glaser R., Crespin T., and Carson III W.E. Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain Behav. Immun. 21 (2007) 953-961
8. Andersen B.L., Karlsson J.A., Anderson B., and Tewfik H.H. Anxiety and cancer treatment: response to stressful radiotherapy. Health Psychol. 3 (1984) 535-551
9. Antoni M.H. Stress Management Intervention for Women with Breast Cancer (2003), American Psychological Association Press, Washington, DC
10. Antoni M.H. Stress management effects on psychological, endocrinological and immune function in men with HIV: empirical support for a psychoneuroimmunological model. Stress 6 (2003) 173-188
11. Antoni M.H., Lehman J.M., Kilbourn K.M., Boyers A.E., Culver J.L., Alferi S.M., et al. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 20 (2001) 20-32
12. Antoni M.H., and Lutgendorf S. Psychosocial Factors and Disease Progression in Cancer. Curr. Dir. Psychol. Sci. 16 (2007) 42-46
13. Antoni M.H., Lutgendorf S., Cole S., Dhabhar F., Sephton S., McDonald P., Stefanek M., and Sood A. The influence of biobehavioral factors on tumor biology, pathways and mechanisms. Nat. Rev. Cancer 6 (2006) 240-248
14. Antoni M.H., Wimberly S., Lechner S., Kazi A., Sifre T., Urcuyo K., Phillips K., Smith R., Petronis V., Guellati S., Wells K., Blomberg B., and Carver C.S. Stress management intervention reduces cancer-specific thought intrusions and anxiety symptoms among women undergoing treatment for breast cancer. Am. J. Psychiatry 163 (2006) 1791-1797
15. Antoni M.H., Lechner S., Kazi A., Wimberly S., Sifre T., Urcuyo K., Phillips K., Gluck S., and Carver C.S. How stress management improves quality of life after treatment for breast cancer. J. Consult. Clin. Psychol. 74 (2006) 1143-1152
16. Baron R.M., and Kenny D.A. The moderator-mediator variable distinction in social psychology research: conceptual, strategic and statistical considerations. J. Pers. Soc. Psychol. 51 (1986) 1173-1182
17. Baxevanis C.N., Reclos G.J., Gritzapis A.D., Dedousis G.V., Missitzis I., and Papamichail M. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 72 (1993) 491-501
18. Beck A.T., and Emery G. Anxiety Disorders and Phobias: A Cognitive Perspective (1985), Basic Books, New York
19. Bernstein B., and Borkovec T. Progressive Muscle Relaxation Training: A Manual for the Helping Professions (1973), Research Press, Champaign, IL
20. Ben-Eliyahu S., Page G., Yimura R., et al. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 80 (1999) 880-888
21. Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology. Brain Behav. Immun. 17 suppl 1 (2003) S27-S36
22. Bloom J.R., et al. Psychological response to mastectomy: a prospective comparison study. Cancer 59 (1987) 189-196
23. Blomberg, B., Alvarez, J., Diaz, A., Romero, M., Lechners, S., Carver, C.S., Holly, H., Antoni, M.H., (submitted for Publication). Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery.
24. Carlson L.E., Speca M., Patel K.D., and Faris P. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain, Behav. Immun. 21 (2007) 1038-1049
25. Carver C.S., Pozo C., Harris S.D., Noriega V., Scheier M.F., Robinson D.S., et al. How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J. Pers. Soc. Psychol. 65 (1993) 375-390
26. Cella D.F., and Tross S. Psychological adjustment to survival from Hodgkin's disease. J. Consult. Clin. Psychol. 54 (1986) 616-622
27. Cohen M., Klein E., Kuten A., Fried G., Zinder O., and Pollack S. Increased emotional distress in daughters of breast cancer patients is associated with decreased natural cytotoxic activity, elevated levels of stress hormones and decreased secretion of Th1 cytokines. Int. J. Cancer 100 (2002) 347-354
28. Cruess D.G., Antoni M.H., McGregor B.A., Kilbourn K.M., Boyers A.E., Alferi S.M., et al. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom. Med. 62 (2000) 304-308
29. DeRijk R., Michelson D., Karp B., Petrides J., Galliven E., Deuster P., et al. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J. Clin. Endocrinol. Metab. 82 (1997) 2182-2191
30. Derogatis L.R. The Affects Balance Scale (1996), Clinical Psychometric Research, Baltimore, MD
31. Fensterheim H., and Baer J. Don't Say Yes When You Want to Say No (1975), David McKay, New York
32. DeVita, V., Hellman, S., Rosenberg, S. 1997. Cancer: Principles and Practice of Oncology. fifth ed. In: Lippincott-Raven, Philadelphia, PA..
33. Edmonds C.V., Lockwood G.A., and Cunningham A.J. Psychological responses to long term group therapy: a randomized trial with metastatic breast cancer patients. Psychooncology 8 (1999) 74-91
34. Elenkov I.J., and Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol. Metab. 10 (1999) 359-368
35. Elsasser-Beile U., von Kleist S., and Martin M. Comparison of mitogen- and virus-induced interferon production in whole blood cell cultures of patients with various solid carcinomas and controls. Tumour Biol. 13 (1992) 358-363
36. Elsasser-Beile U., von Kleist S., Stahle W., Schurhammer-Fuhrmann C., Monting J.S., and Gallati H. Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal cell carcinoma. Cancer 71 (1993) 231-236
37. Enders C.K. A primer on the use of modern missing-data methods in psychosomatic medicine research. Psychosom. Med. 68 (2006) 427-436
38. Fekedulegn D., Andrew M., Burchfiel O., Violanti J., Hartley T., Charles L., and Miller D. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom. Med. 69 (2007) 651-659
39. Fischer J.R., Schindel M., Bulzebruck H., Lahm H., Krammer P.H., and Drings P. Decrease of interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer. Ann. Oncol. 8 (1997) 457-461
40. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32 (1959) 50-55
41. Herbert T.B., and Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom. Med. 55 (1993) 364-379
42. Herbert T.B., and Cohen S. Depression and immunity: a meta-analytic review. Psychol. Bull. 113 (1993) 472-486
43. Holland, J. (1998). The role of psychosocial factors in the development of cancer. In: Textbook of Psycho-Oncology. Oxford University Press, New York.
44. Horowitz M., Wilner N., and Alvarez W. Impact of event scale. Psychosom. Med. 41 (1979) 209-218
45. Irvine D., Brown B., Crooks D., Roberts J., and Browne G. Psychosocial adjustment in women with breast-cancer. Cancer 67 (1991) 1097-1117
46. Jacobsen P.B., Widows M.R., Hann D.M., Andrykowski M.A., Kronish L.E., and Fields K.K. Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosom. Med. 60 (1998) 366-371
47. Kang D., and Fox C. Th1 and Th2 cytokine responses to academic stress. Res. Nurs. Health 24 (2001) 245-257
48. Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., and Schreiber R.D. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA 95 (1998) 7556-7561
49. Kiecolt-Glaser J., and Glaser R. Methodological issues in behavioral immunology research with humans. Brain Behav. Immun. 2 (1988) 67-78
50. Kissane D.W., Boloch S., Smith G.C., et al. Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial. Psychooncology 12 (2003) 532-546
51. Konjevic G., and Spuzic I. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer. Neoplasma 40 (1993) 81-85
52. Larson M., Duberstein P., Talbot N., Caldwell C., and Moynihan J. A pre-surgical psychosocial intervention for breast cancer patients: psychological distress and the immune response. J. Psychosom. Res. 48 (2000) 187-194
53. Levy S., Herberman R., and Whiteside T. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom. Med. 52 (1990) 73-85
54. Luebbert K., Dahme B., and Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology 10 (2001) 490-502
55. McGregor B.A., Antoni M.H., Boyers A., Alferi S.M., Blomberg B.B., and Carver C.S. Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer. J. Psychosom. Res. 56 (2004) 1-8
56. Meyer T.J., and Mark M.M. Effects of psychosocial interventions with adult cancer patients: A meta-analysis of randomized experiments. Health Psychol. 14 (1995) 101-108
57. Miller J.S., Tessmer-Tuck J., Pierson B.A., Weisdorf D., McGlave P., Blazar B.R., et al. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity. Biol. Blood Marrow Transplant. 3 (1997) 34-44
58. Morrow G.R., Roscoe J.A., Hickok J.T., Andrews P.R., and Matteson S. Nausea and emesis: evidence for a biobehavioral perspective. Support. Care Cancer 10 (2002) 96-105
59. Muthén B. Latent variable modeling with longitudinal and multilevel data. In: Raferty A. (Ed). Sociological Methodology (1997), Blackwell, Boston 453-480
60. Penman D.T., Bloom J.R., Fotpoulos S., Cook M.R., Holland J.C., Gates C., Flamer D., Murawski B., Ross R., Brandt U., Muenz L.R., and Pee D. The impact of mastectomy on self-concept and social function: a combined cross-sectional and longitudinal study with comparison groups. Women and Health 11 (1987) 101-130
61. Phillips, K., Antoni, M.H., Lechner, S., Blomberg, B., Llabre, M., Avisar, E., Gluck, S., DehHagopian, R., Carver, C. in press. Stress management intervention reduces serum cortisol and increases relaxation during treatment for non-metastatic breast cancer. Psychosom. Med.
62. Reichlin S. Neuroendocrine-immune interactions. N. Engl. J. Med. 329 (1993) 1246-1253
63. Roussel E., Gingras M.C., Grimm E.A., Bruner J.M., and Moser R.P. Predominance of a type 2 intratumoral immune response in fresh tumour-infiltrating lymphocytes from human gliomas. Clin. Exp. Immun. 105 (1996) 344
64. Saito S., Umekage H., Nishikawa K., Morii T., Narita N., Enomoto M., et al. Interleukin 4 (IL-4) blocks the IL-2-induced increased in natural killer activity and DNA synthesis of decidual CD16-CD56bright NK cells by inhibiting expression of the IL-2 receptor alpha, beta, and gamma. Cell Immunol. 170 (1996) 71-77
65. Savard J., Simard S., Ivers H., and Morin C.M. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer. Part I: sleep and psychological effects. J. Clin. Oncol. 23 25 (2005) 6083-6096
66. Savard J., Simard S., Ivers H., and Morin C.M. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer. Part II: immunologic effects. J. Clin. Oncol. 23 25 (2005) 6097-6106
67. Savino W., and Dardenne M. Immune-neuroendocrine interactions. Immunol. Today 16 (1995) 318-322
68. Schedlowski M., Jungk C., Schimanski G., Tewes U., and Schmoll H.J. Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: an exploratory study. Psychooncology 3 (1994) 181-187
69. Schwab J.J., Bialow M.R., Clemmons R.S., and Holzer C.E. Hamilton rating scale for depression with medical in-patients. Br. J. Psychiatry 113 (1967) 83-88
70. Segerstom S. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130 (2004) 601-630
71. Sephton S.E., Sapolsky R.M., Kraemer H.C., and Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 92 (2000) 994-1000
72. Shakhar G., and Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?. Ann. Surg. Oncol. 16 (2003) 972-992
73. Smith P.C., Hobish A., Lin D.L., Culig Z., and Keller E.T. Interleukin-6 and prostate cancer progression. Cytokine Growth Factor Rev. 12 (2001) 33-40
74. Spencer S.M., Lehman J.M., Wynings C., Arena P., Carver C.S., Antoni M.H., et al. Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients. Health Psychol. 18 (1999) 159-168
75. Stanton A.L., and Snider P.R. Coping with a breast cancer diagnosis: a prospective study. Health Psychol. 12 (1993) 16-23
76. Street S.E., Cretney E., and Smyth M.J. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis. Blood 97 (2001) 192-197
77. Taylor S.E., Repetti R.L., and Seeman T. Health psychology: what is an unhealthy environment and how does it get under the skin?. Ann. Rev. Psychol. 48 (1997) 411-447
78. Tartour E., Gey A., Sastre-Garau X., Lombard S.I., Mosseri V., and Fridman W.H. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J. Natl. Cancer Inst. 90 (1998) 287-294
79. Thaker P., Han L., Kamat A., Arevalo J., Takahashi R., Chunhua L., Jennings N.B., Armaiz-Pena G., Bankson J.A., Ravoori M., et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12 (2006) 939-944 (Electronic version)
80. Thomas C., Madden F., and Jehu D. Psychological effects of stomas-I. Psychosocial morbidity one year after surgery. J. Psychosom. Res. 31 (1987) 311-316
81. Touitou Y., Levi F., Bogdan A., Benavides M., Bailleul F., and Misset J.L. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J. Cancer Res. Clin. Oncol. 121 (1995) 181-188
82. Trask P.C., Paterson A.G., Griffith K.A., Riba M.B., and Schwartz J.L. Cognitive-behavioral intervention for distress in patients with melanoma. Cancer 98 (2003) 854-864
83. van der Pompe G., Antoni M.H., and Heijnen C. The relations of plasma ACTH and cortisol levels with the distribution and function of peripheral blood cells in response to a behavioral challenge in breast cancer: an empirical exploration by means of statistical modeling. Int. J. Behav. Med. 4 (1997) 145-167
84. van der Pompe G., Antoni M.H., and Heijnen C. The effects of surgical stress and psychological stress on the immune function of operative cancer patients. Psychol. Health 13 (1998) 1015-1026
85. van't Spijker A., Trijsburg R.W., and Duivenvoorden H.J. Psychological sequelae of cancer diagnosis: a meta-analytic review of 58 studies after 1980. Psychosom. Med. 59 (1997) 280-293
86. Weisman A.D., and Worden J.W. The existential plight in cancer: significance of the first 100 days. Int. J. Psychiatry Med. 7 (1976) 1-15
87. Whiteside T.L., and Herberman R.B. The role of natural killer cells in human disease. Clin. Immunol. Immunopathol. 53 (1989) 1-23
88. Woodworth C.D., Lichti U., Simpson S., Evans C.H., and DiPaolo J.A. Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. Cancer Res. 52 (1992) 456-463
89. Witek-Janusek L., Albuquerque K., Chroniak K.R., Chroniak C., Durazo-Arvizu R., and Mathews H. Effect of mindfulness-based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain Behav. Immun. 22 (2008) 969-981
90. Yehuda R. Hypothalamic-pituitary-adrenal alterations in PTSD: are they relevant to understanding cortisol alterations in cancer?. Brain Behav. Immun. 17 (2003) S73-S83
91. Zou W. Immunosuppressive networks in the tumor environment and their therapeutic relevance. Nat. Rev. Cancer 5 (2005) 263-274